The data from the Phase 1/1b clinical trial of soquelitinib in patients with T cell lymphoma continues to demonstrate strong indications of anti-tumor activity in a significant number of patients,” ...
News Medical on MSN8d
Promising active ingredient for lupus therapyLupus is an autoimmune disease where the body’s immune system attacks its own tissues and organs, causing inflammation and ...
5d
News-Medical.Net on MSNSemi-synthetic bile acid could be a promising therapeutic option for TH17-mediated intestinal diseasesA research team from the Medical University of Vienna has made further progress in the treatment of intestinal inflammation.
A research team has made further progress in the treatment of intestinal inflammation. A study shows that the semi-synthetic bile acid NorUDCA inhibits in the intestine the formation of ...
T cells are white blood cells that are important for adaptive immunity. They have unique cell surface receptors that are generated by randomly assorting genes. These receptors allow T cells to ...
The research team profiled more than 47,000 T cells including acutely infected, treated, and uninfected cells, to then identify helper T cells (which detect infections), memory cells, naïve cells ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results